InvestorsHub Logo

tryz

12/09/17 11:20 AM

#15434 RE: starteam003 #15433

Ibio has a huge debt load to repay , hence the increase in os share count and nothing on the horizon to outdated biotech patents with no new trials on the horizon or revenue.....read the latest 10k filing!....imho,tryz